Showing results (2111-2120 of 3,978) with videos related to

Sort By:
Pageof 398
European Journal of Heart Failure|September 25, 2007
Clinical trials update from the European Society of Cardiology Congress 2007: 3CPO, ALOFT, PROSPECT and statins for heart failureJohn G F Cleland, Ahmed Tageldien Abdellah, Olga Khaleva, et al.
European Journal of Heart Failure|October 6, 2021
COVID-19 vaccination in patients with heart failure: a position paper of the Heart Failure Association of the European Society of CardiologyGiuseppe Rosano, Ewa A Jankowska, Robin Ray, et al.
European Journal of Heart Failure|February 4, 2022
Drug therapy for heart failure with reduced ejection fraction: what is the 'right' dose?Toru Kondo, Pardeep S Jhund, John J V McMurray
European Journal of Heart Failure|October 25, 2021
Death of a child and the risk of heart failure: a population-based cohort study from Denmark and SwedenDang Wei, Jiong Li, Imre Janszky, et al.
European Journal of Heart Failure|June 28, 2019
Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathyJohann Bauersachs, Tobias König, Peter van der Meer, et al.
European Journal of Heart Failure|June 19, 2019
Mid-regional pro-atrial natriuretic peptide for the early detection of non-acute heart failureAisha Gohar, Frans H Rutten, Hester den Ruijter, et al.
European Journal of Heart Failure|May 29, 2019
Initiation of sacubitril/valsartan in haemodynamically stabilised heart failure patients in hospital or early after discharge: primary results of the randomised TRANSITION studyRolf Wachter, Michele Senni, Jan Belohlavek, et al.
European Journal of Heart Failure|September 30, 2021
A randomized clinical trial on the short-term effects of 12-week sacubitril/valsartan vs. enalapril on peak oxygen consumption in patients with heart failure with reduced ejection fraction: results from the ACTIVITY-HF studyMartin Halle, Christoph Schöbel, Ephraim B Winzer, et al.
European Journal of Heart Failure|October 11, 2021
Plasma biomarkers associated with adverse outcomes in patients with calcific aortic stenosisMahesh K Vidula, Alena Orlenko, Lei Zhao, et al.
European Journal of Heart Failure|March 18, 2022
Impact of the COVID-19 pandemic on prescription of sacubitril/valsartan in ItalyGiuseppe M C Rosano, Simone Celant, Pier Paolo Olimpieri, et al.
Pageof 398